Prevalence of sarcopenic obesity and association with metabolic syndrome in an adult Iranian cohort: The Fasa PERSIAN cohort study

被引:7
|
作者
Siervo, Mario [1 ]
Rubele, Sofia [2 ,3 ]
Shannon, Oliver M. [3 ]
Prado, Carla M. [4 ]
Donini, Lorenzo Maria [5 ]
Zamboni, Mauro [2 ]
Homayounfar, Reza [6 ,7 ]
Farjam, Mojtaba [6 ]
Faghih, Shiva [8 ]
Mazidi, Mohsen [9 ,10 ]
机构
[1] Univ Nottingham, Queens Med Ctr, Sch Life Sci, Div Physiol Pharmacol & Neurosci, Nottingham, England
[2] Univ Verona, Hlth Aging Ctr, Dept Surg Dent Pediat & Gynecol, Div Geriatr, Verona, Italy
[3] Newcastle Univ, Human Nutr Res Ctr, Populat Hlth Sci Inst, Newcastle Upon Tyne, Tyne & Wear, England
[4] Univ Alberta, Dept Agr Food & Nutr Sci, Human Nutr Res Unit, Edmonton, AB, Canada
[5] Sapienza Univ Rome, Dept Expt Med Med Pathophysiol, Food Sci & Endocrinol Sect, Rome, Italy
[6] Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran
[7] Shahid Beheshti Univ Med Sci, Fac Nutr Sci & Food Technol, Natl Nutr & Food Technol Res Inst, WHO Collaborating Ctr, Tehran, Iran
[8] Shiraz Univ Med Sci, Sch Nutr & Food Sci, Dept Community Nutr, Shiraz, Iran
[9] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England
[10] Kings Coll London, Dept Nutr Sci, London, England
关键词
Low- and Middle-income Countries; metabolic risk; obesity; sarcopenia; SKELETAL-MUSCLE MASS; CHRONIC NONCOMMUNICABLE DISEASES; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; BODY-COMPOSITION; REFERENCE VALUES; NATIONAL-HEALTH; VISCERAL FAT; RISK-FACTOR; INFLAMMATION;
D O I
10.1111/cob.12459
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sarcopenic obesity (SO) is characterised by a concomitant high fat mass (FM) and low fat free mass (FFM) leading to an increased cardio-metabolic risk. This analysis aims to estimate the SO prevalence in Iranian adults and evaluate the association of SO with metabolic syndrome (MetS) risk. This cross-sectional analysis included 4296 subjects (age 35-70 years, 55.2% females). Body composition parameters, measured by bioelectrical impedance included: FM, FFM, appendicular lean mass (ALM) and skeletal mass index. SO was classified according to five criteria: (1) FM%-SMI; (2) FM%-ALM/% weight (wt%); (3) FM%-ALM/body mass index (BMI); (4) Residuals of ALM and FM and (5) FM/FFM Ratio. Multivariate logistic regression was applied to explore the association between SO models with MetS risk stratified by gender. Receiving operating characteristic (ROC) curves were used to identify the best FM/FFM ratio cut-off value for detecting MetS cases in males and females. The prevalence of SO varied between 4% and 26% depending upon the classification method. The prevalence of MetS was 12.8% and 31.6% in males and females, respectively. SO models based on ALM/wt% and FM/FFM ratio showed the strongest association with MetS risk in males (OR: 11.5, 95%CI: 7.5-17.7, p < 0.001 and OR: 10.1, 95%CI: 6.9-14.7, p < 0.001, respectively) and females (OR: 4.1, 95%CI: 3.0-5.6, p < 0.001 and OR: 4.6, 95%CI: 3.5-5.9, p < 0.001, respectively). SO is a prevalent condition in an adult Iranian population and the ALM/wt% and the FM/FFM ratio models of SO appeared to be associated with higher MetS risk.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Comments on "Diet quality in relation to the risk of hypertension among Iranian adults: cross-sectional analysis of Fasa PERSIAN cohort study"
    Ghobadi, Saeed
    Jafari, Alireza
    NUTRITION JOURNAL, 2022, 21 (01)
  • [42] The association of sleep duration and metabolic syndrome in the Bandare-Kong cohort study, a cross-sectional survey (finding from PERSIAN cohort study)
    Rafati, Shideh
    Isheh, Maryam
    Azarbad, Abnoos
    Ghadiri Soufi, Farhad
    Rahimi, Arash
    Kheirandish, Masoumeh
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
  • [43] The association of sleep duration and metabolic syndrome in the Bandare-Kong cohort study, a cross-sectional survey (finding from PERSIAN cohort study)
    Shideh Rafati
    Maryam Isheh
    Abnoos Azarbad
    Farhad Ghadiri Soufi
    Arash Rahimi
    Masoumeh Kheirandish
    Diabetology & Metabolic Syndrome, 13
  • [44] Comments on “Diet quality in relation to the risk of hypertension among Iranian adults: cross-sectional analysis of Fasa PERSIAN cohort study”
    Saeed Ghobadi
    Alireza Jafari
    Nutrition Journal, 21
  • [45] Framingham risk scores for determination the 10-year risk of cardiovascular disease in participants with and without the metabolic syndrome: results of the Fasa Persian cohort study
    Dehghan, Azizallah
    Jahangiry, Leila
    Khezri, Rozhan
    Jafari, Alireza
    Pezeshki, Babak
    Rezaei, Fatemeh
    Aune, Dagfinn
    BMC ENDOCRINE DISORDERS, 2024, 24 (01)
  • [46] Association between adherence to the Mediterranean diet with cardiometabolic risk factors: a cross-sectional study on PERSIAN cohort study in Fasa
    Milad Bagheri
    Mehran Nouri
    Reza Homayounfar
    Masoumeh Akhlaghi
    Scientific Reports, 13
  • [47] Improving the functional detection of sarcopenic obesity: prevalence and handgrip scoring in the OBESAR cohort
    Pouget, Melanie
    Pinel, Alexandre
    Miolanne, Magalie
    Gentes, Elodie
    Picard, Mathilde
    Martinez, Ruben
    Mulliez, Aurelien
    Guillet, Christelle
    Farigon, Nicolas
    Boirie, Yves
    OBESITY, 2024, 32 (12) : 2237 - 2245
  • [48] Prevalence of metabolic syndrome and its components among a population-based study in south of Iran, PERSIAN Kharameh cohort study
    Nikbakht, Hossein-Ali
    Rezaianzadeh, Abbas
    Seif, Mozhgan
    Ghaem, Haleh
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2020, 8 (03): : 678 - 683
  • [49] The association between sarcopenic obesity, metabolic risk and the metabolic syndrome in Northern Italian adults
    Lara, J.
    Powell, M.
    Siervo, M.
    Batezzati, A.
    Leone, A.
    Tagliabue, A.
    Spadafranca, A.
    Bertolli, S.
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2016, 75 (OCE3) : E155 - E155
  • [50] Association Between Metabolic Syndrome and Mortality: Prospective Cohort Study
    Li, Wenzhen
    Chen, Dajie
    Peng, Ying
    Lu, Zuxun
    Kwan, Mei-Po
    Tse, Lap Ah
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2023, 9